MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

JM Mitchell, M Ot'alora G, B van der Kolk, S Shannon… - Nature Medicine, 2023 - nature.com
This multi-site, randomized, double-blind, confirmatory phase 3 study evaluated the efficacy
and safety of 3, 4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) versus …

Therapeutic mechanisms of psychedelics and entactogens

BD Heifets, DE Olson - Neuropsychopharmacology, 2024 - nature.com
Recent clinical and preclinical evidence suggests that psychedelics and entactogens may
produce both rapid and sustained therapeutic effects across several indications. Currently …

[HTML][HTML] Alleviating anxiety and taming trauma: novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder

N Singewald, SB Sartori, A Reif, A Holmes - Neuropharmacology, 2023 - Elsevier
Psychiatric disorders associated with psychological trauma, stress and anxiety are a highly
prevalent and increasing cause of morbidity worldwide. Current therapeutic approaches …

[HTML][HTML] MDMA-assisted psychotherapy for PTSD: growing evidence for memory effects mediating treatment efficacy

M Sarmanlu, KPC Kuypers, P Vizeli… - Progress in Neuro …, 2024 - Elsevier
The application of MDMA in conjunction with psychotherapy has in recent years seen a
resurgence of clinical, scientific, and public interest in the treatment of posttraumatic stress …

Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors

SC Woodburn, CM Levitt, AM Koester… - ACS Chemical …, 2024 - ACS Publications
A variety of classic psychedelics and MDMA have been shown to enhance fear extinction in
rodent models. This has translational significance because a standard treatment for post …

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder

SP Singleton, JB Wang, M Mithoefer, C Hanlon… - Frontiers in …, 2023 - frontiersin.org
Introduction 3, 4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) for post-
traumatic stress disorder (PTSD) has demonstrated promise in multiple clinical trials. MDMA …

Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great …

K Stocker, ME Liechti - Journal of Psychopharmacology, 2024 - journals.sagepub.com
Science on methylenedioxymethamphetamine (MDMA) and MDMA-like substances is faced
with the unique situation that this class of psychoactive agents is referred to with two basic …

MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations

S Kangaslampi, J Zijlmans - European child & adolescent psychiatry, 2023 - Springer
Methylenedioxymetamphetamine (MDMA)-assisted psychotherapy (MDMA-AP) is a
proposed treatment for posttraumatic stress disorder (PTSD) that may be approved for adults …

Examining the role of oxytocinergic signaling and neuroinflammatory markers in the therapeutic effects of MDMA in a rat model for PTSD

H Avgana, RS Toledano, I Akirav - Pharmaceuticals, 2024 - mdpi.com
MDMA-assisted psychotherapy has shown potential as an effective treatment for post-
traumatic stress disorder (PTSD). Preclinical studies involving rodents have demonstrated …

Altered states and social bonds: Effects of MDMA and serotonergic psychedelics on social behavior as a mechanism underlying substance-assisted therapy

Y Schmid, AK Bershad - Biological Psychiatry: Cognitive Neuroscience and …, 2024 - Elsevier
Background There has been renewed interest in the use of 3, 4-methylenedioxy-
methamphetamine (MDMA) and serotonergic psychedelics in the treatment of multiple …